CSIMarket Company Name, Ticker, Customers, else..


Protagonist Therapeutics inc   (NASDAQ: PTGX)
Other Ticker:  
 

Protagonist Therapeutics inc

PTGX's Fundamental analysis



Protagonist Therapeutics Inc 's sales fell by -88.89 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 251

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.5 %

Protagonist Therapeutics Inc faced net loss in contrast to the net income a year ago in first quarter of 2025

• More on PTGX's Growth


Protagonist Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Protagonist Therapeutics Inc realized cash reduction of $ -0.52 per share in trailing twelve-month period.
Company
111.22
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.76.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.


• More on PTGX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,855,366
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 10.94

Protagonist Therapeutics Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Protagonist Therapeutics Inc realized cash outflow of $ -0.52per share in trailing twelve-month period.
Company
111.22
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.76.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.

Protagonist Therapeutics Inc Price to Book Ratio is at 5.05 lower than Industry Avg. of 35.08. and higher than S&P 500 Avg. of 0.01

• More on PTGX's Valuation

•  Market Capitalization (Millions $) 3,483
•  Shares Outstanding (Millions) 63
•  Employees 112
•  Revenues (TTM) (Millions $) 208
•  Net Income (TTM) (Millions $) 56
•  Cash Flow (TTM) (Millions $) -33
•  Capital Exp. (TTM) (Millions $) -2
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,855,366
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 10.94

•  Market Capitalization (Millions $) 3,483
•  Shares Outstanding (Millions) 63
•  Employees 112
•  Revenues (TTM) (Millions $) 208
•  Net Income (TTM) (Millions $) 56
•  Cash Flow (TTM) (Millions $) -33
•  Capital Exp. (TTM) (Millions $) -2





  Ratio
•   Capital Ratio (MRQ) 17.26
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.08
•  Asset Turnover Ratio (TTM) 0.31
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com